DH

+ Watchlist + Portfolio

Definitive Healthcare Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.72
52-Week Range: $0.61 – $4.35
Market Cap: $77.66M
P/E (TTM): —
EPS (TTM): -1.62
Dividend Yield: —

Advanced Metrics

Price/Book: 0.54
PEG Ratio: —
Return on Equity: -78.37%
Return on Assets: -1.94%
Gross Margin: 83.76%
Operating Margin: -8.55%
Profit Margin: -72.28%
Current Ratio: 1.86
Debt/Equity: 0.89
Total Debt: $167.06M
Free Cash Flow: $50.35M
Revenue Growth: -9.10%
Earnings Growth: —
Enterprise Value: $103.00M

DH Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$222.65M	$251.41M	$252.20M	$241.52M
Cost of Revenue	$42.63M	$47.48M	$54.73M	$58.25M
Gross Profit	$180.03M	$203.93M	$197.47M	$183.28M
Research & Development	$34.89M	$42.44M	$36.52M	$34.78M
Selling, General & Admin	$141.15M	$153.40M	$133.07M	$133.26M
Operating Expenses	$216.18M	$234.84M	$207.21M	$203.86M
Operating Income	-$36.15M	-$30.91M	-$9.74M	-$20.58M
EBITDA	$26.23M	-$241.23M	-$567.24M	-$141.86M
Pretax Income	-$41.88M	-$308.18M	-$633.75M	-$209.26M
Income Tax	-$17.70M	-$18.55M	-$42.30M	-$9.96M
Net Income	-$7.22M	-$202.39M	-$413.12M	-$138.93M
Diluted EPS	-0.06	-1.79	-3.54	-1.30
Diluted Shares	101.11M	112.76M	116.64M	106.65M

DH Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$146.93M	$130.98M	$105.38M	$163.63M
Receivables	$58.80M	$59.25M	$53.23M	$51.98M
Current Assets	$413.75M	$393.93M	$370.17M	$257.61M
Total Assets	$2.12B	$1.83B	$1.09B	$735.49M
Current Liabilities	$140.61M	$170.68M	$161.16M	$156.79M
Long-Term Debt	$255.76M	$242.57M	$229.37M	$156.09M
Total Debt	$275.85M	$267.93M	$253.11M	$172.67M
Total Liabilities	$640.68M	$626.73M	$482.19M	$356.50M
Retained Earnings	-$25.06M	-$227.45M	-$640.57M	-$779.51M
Shareholders' Equity	$948.92M	$861.36M	$444.38M	$281.11M
Working Capital	$273.13M	$223.25M	$209.01M	$100.82M
Net Debt	$117.42M	$125.34M	$137.74M	$1.21M

DH Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$35.58M	$41.19M	$58.20M	$53.78M
Capital Expenditure	-$8.33M	-$2.98M	-$12.34M	-$16.72M
Free Cash Flow	$27.25M	$38.21M	$45.85M	$37.06M
Depreciation & Amortisation	$56.90M	$51.75M	$51.67M	$56.11M
Stock-Based Compensation	$36.43M	$48.74M	$38.09M	$29.14M
Investing Cash Flow	-$248.90M	-$31.78M	-$26.41M	$153.88M
Financing Cash Flow	-$26.70M	-$25.58M	-$56.75M	-$150.79M
Dividends Paid	-$12.87M	-$12.28M	—	—
Share Repurchases	$0.00	$0.00	-$22.37M	-$49.45M
Net Change in Cash	-$240.02M	-$16.18M	-$24.96M	$56.86M

DH Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$59.19M	$60.75M	$60.05M	$61.53M	$55.93M
Cost of Revenue	$15.43M	$14.14M	$14.05M	$14.63M	$14.28M
Gross Profit	$43.76M	$46.61M	$45.99M	$46.91M	$41.65M
Research & Development	$9.30M	$7.97M	$7.55M	$9.95M	$6.50M
Selling, General & Admin	$32.92M	$33.14M	$32.74M	$34.46M	$31.66M
Operating Expenses	$50.75M	$50.11M	$49.37M	$53.62M	$46.49M
Operating Income	-$6.99M	-$3.50M	-$3.38M	-$6.71M	-$4.84M
EBITDA	-$149.73M	$8.52M	-$209.00K	-$439.00K	-$179.91M
Pretax Income	-$165.98M	-$8.81M	-$17.27M	-$17.20M	-$195.79M
Income Tax	-$10.89M	$456.00K	$524.00K	-$53.00K	-$3.44M
Net Income	-$107.23M	-$7.55M	-$14.84M	-$9.31M	-$138.62M
Diluted EPS	-0.95	-0.07	-0.14	-0.09	-1.32
Diluted Shares	104.68M	106.82M	103.78M	103.36M	104.68M

DH Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$106.10M	$80.98M	$108.32M	$163.63M	$157.65M
Receivables	$42.92M	$37.51M	$34.37M	$51.98M	$38.94M
Current Assets	$273.44M	$249.19M	$246.32M	$257.61M	$245.76M
Total Assets	$808.66M	$770.14M	$755.53M	$735.49M	$514.74M
Current Liabilities	$156.08M	$151.25M	$153.88M	$156.79M	$140.40M
Long-Term Debt	$162.38M	$160.28M	$158.19M	$156.09M	$153.99M
Total Debt	$180.61M	$177.96M	$175.40M	$172.67M	$169.84M
Total Liabilities	$372.75M	$358.91M	$365.86M	$356.50M	$324.04M
Retained Earnings	-$747.80M	-$755.35M	-$770.19M	-$779.51M	-$918.13M
Shareholders' Equity	$322.78M	$303.62M	$284.85M	$281.11M	$146.23M
Working Capital	$117.36M	$97.94M	$92.44M	$100.82M	$105.35M
Net Debt	$65.04M	$88.05M	$58.62M	$1.21M	$5.09M

DH Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$26.07M	$9.30M	$15.69M	$2.72M	$11.56M
Capital Expenditure	-$7.71M	-$2.29M	-$2.28M	-$4.44M	-$3.20M
Free Cash Flow	$18.36M	$7.01M	$13.41M	-$1.72M	$8.36M
Depreciation & Amortisation	$13.82M	$14.34M	$14.06M	$13.89M	$13.25M
Stock-Based Compensation	$7.32M	$6.98M	$6.68M	$8.16M	$5.22M
Investing Cash Flow	$83.55M	-$10.16M	$24.14M	$56.35M	-$6.22M
Financing Cash Flow	-$109.71M	-$24.70M	-$12.47M	-$3.91M	-$10.88M
Dividends Paid	—	—	$0.00	—	—
Share Repurchases	-$21.16M	-$19.08M	-$9.22M	$0.00	$0.00
Net Change in Cash	-$95.00K	-$25.56M	$27.36M	$55.16M	-$5.53M

Market Snapshot

About

Definitive Healthcare Corp. provides healthcare commercial intelligence and data analytics solutions to life sciences companies, healthcare providers, and other healthcare organizations. The company aggregates and analyzes data on hospitals, physicians, healthcare facilities, and claims information to deliver actionable insights for sales, marketing, and clinical research applications. Definitive Healthcare's SaaS platform helps pharmaceutical companies identify prescribers, medical device manufacturers target facilities, and healthcare providers benchmark performance. The company maintains databases covering millions of healthcare providers and billions of claims transactions updated continuously.